ELMMB logo
Facebook logo Twitter logo
Menu
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Within the UK, the Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health aim to enhance and safeguard the health of the public by ensuring that medicines and medical devices work and are acceptably safe. No product is risk-free. Underpinning their work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks.

  • The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe.
  • No product is risk-free. Underpinning the work of the MHRA lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks.
  • The MHRA keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem.
  • The MHRA aim to make as much information as possible publicly available. The MHRA enable greater access to products, and the timely introduction of innovative treatments and technologies that benefit patients and the public.
  • The MHRA encourage everyone - the public and healthcare professionals as well as industry - to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action. To find out more about the MHRA click here...

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

13th December 2018   MHRA Lidocaine teething products: talk to your pharmacist - key messages for parents and care givers
13th December 2018   MHRA Alert - Oral lidocaine-containing products for infant teething: only to be available under the supervision
                                                                  of a pharmacist
30th November 2018   MHRA Press Release - MHRA recalls Valsartan blood pressure and heart medication from pharmacies
8th October 2018         MHRA Press Release - Roche CoaguChek device producing inaccurate results
4th October 2018         MHRA Press Release - Digital pregnancy tests recalled in new alert amid false positive results
31st July 2018               MHRA News Story - Batches of Durex condoms recalled: People urged to check their batch numbers
26th April 2018             MHRA News Story - 'Couple sentenced for operating fake online pharmacy'
24th April 2018             MHRA Press Release - 'Valproate banned without the pregnancy prevention programme'
15th March 2018          MHRA Press Release - 'Keep Head Lice Treatments away from naked flame'
21st February 2018      MHRA - Batches of Ventolin Accuhaler and Seretide Accuhaler asthma inhalers recalled

MHRA Company-led Drug alerts

click here to access the most recent alerts